Home Study Activities

Hepatitis C Module #1: The abCs of HCV

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed.

Learn More ►

Hepatitis C Module #3: HCV Drug Therapy Management

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed.

Learn More ►

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed.

Learn More ►

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Hepatitis C virus (HCV) has become one of the most common infections worldwide. This comprehensive four module program will provide a complete overview of HCV. Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed.

Learn More ►

A Specialty Pharmacy Pipeline Product Update

An update on what is in the pipeline is the focus of this presentation. The most recent approvals and near-term products will be covered.

Learn More ►

Addressing Risks Associated with IV Push Medication Use in Adults

Experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk.

Learn More ►

Adherence Concepts for the Cancer Patient

This educational activity will address the issue of adherence in the oncology patient. Topics to be addressed include the incidence of non-adherence, reasons for non-adherence, and consequences of non-adherence. Strategies to remove barriers to non-adherence and improve the adherence rate will be discussed.

Learn More ►

Adult Vaccines in 2018: Where Do We Start?

Vaccines are an important aspect of public health, and this activity will seek to broaden the conversation about preventative health and how immunizations fit into pharmacy practice.

Learn More ►

Advancing Personalized Treatment of Patients with Hemophilia Through Comprehensive Pharmacokinetic Assessment

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Learn More ►

Arming Specialty Pharmacies with Standards-Based Technologies to Engage Patients and Prescribers

This panel discussion will examine how standards-based technology solutions are aiding specialty pharmacies. Topics will include a review of the landscape of specialty pharmacy and standards, specialty pharmacist-related opioid issues and improving patient onboarding to specialty medications.

Learn More ►

Certification in Specialty Pharmacy Exam - Preparation Course

The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed.

Learn More ►

Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action

This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process.

Learn More ►

Chemotherapy-Induced Nausea and Vomiting and Oral Chemotherapy Related Adverse Events

This activity provides an update for pharmacists on the antiemetic therapies available and techniques for managing the unique adverse events associated with oral chemotherapy.

Learn More ►

Colorectal Cancer

This educational activity will provide an overview of the epidemiology, risk factors, pathology, and staging of CRC. Common treatments used for CRC will be reviewed along with a discussion of adverse effects and recommended monitoring. Strategies to improve the compliance and adherence in CRC patients will also be discussed.

Learn More ►

Contemporary Evaluation and Management of Lung Cancer Targeted Therapies

The management of Lung Cancer is complex and pharmacists require a working knowledge or mastery of treatment options, including appropriateness of therapy, staging consideration, treatment failure, and associated adverse effects.

Learn More ►

Contemporary Practice Pearls for Pulmonary Arterial Hypertension

This activity will focus on individualized treatment strategies for PAH therapy. Faculty will cover insights into PAH pathophysiology, therapies and the most recent data surrounding their uses, and navigating clinical guidelines.

Learn More ►

Creating Impact in the Treatment and Prevention of Recurrent C. Difficile Infection

This activity will address patient education and counseling reminders to reduce the risk of recurrence, patient-specific risk factors for recurrent CDI, recommended and emerging treatments for recurrent CDI, and factors in health-system reduction of rCDI.

Learn More ►

Current Regulatory Landscape in Antibiotic Stewardship

This offering will provide an update of the current regulatory requirements regarding stewardship and describe initiatives and proposed rules on the horizon from government agencies and other organizations. This will include a discussion of stewardship in the acute care, ambulatory and long-term care settings.

Learn More ►

Desensitization to Antibiotic Allergies

This activity will use five clinical scenarios to explore treatment options for patients with antibiotic allergies.

Learn More ►

Dueling Recommendations: When to Use Dual Therapy

This presentation will focus on the highlights and recent developments of combination therapy.

Learn More ►

Emerging Practices in the Management of Community-Acquired Bacterial Pneumonia

This continuing education activity will explore the current prevalence and burden of CABP, discuss practice considerations in the use of rapid diagnostics, and examine studies and data surrounding the use of antibiotics currently available as well as emerging agents in the pipeline.

Learn More ►

Evaluating Practices in the Treatment of HABP/VABP

This activity will discuss the prevention and treatment of HABP/VABP for clinical and infectious diseases pharmacists. Special attention will be given to available and emerging treatment options, along with pertinent patient considerations and monitoring strategies.

Learn More ►

Examining Sterile Compounding for Health-Systems: A Look Ahead to 2020

A discussion surrounding the finalized update to USP <797> and current understanding of USP <800> will ensure learners are up to date on necessary compliance elements for their health-systems.

Learn More ►

Examining Strategies to Manage Antimicrobial Resistance Mechanisms

This activity will discuss mechanisms of resistance, management strategies for highlighted community and hospital-acquired infectious diseases with the most resistance-related concerns, and substitute therapeutic options when guideline or protocol-directed therapies are found to be ineffective.

Learn More ►

Expert Answers: Sterile Compounding in Health Systems

Faculty will shed light on difficult concepts and common concerns related to the implementation of new sterile compounding regulations, while providing attendees with immediate feedback and reinforcement of key points.

Learn More ►

Fertility Module #1: Fertility Care Considerations: Introduction to Infertility for the Specialty Health Care Pharmacist

Module 1 reviews the physiology of reproduction and the effects of hormone regulation on reproduction. The risk factors for infertility as well as the diagnostic tests used in identifying infertility will be discussed.

Learn More ►

Fertility Module #2: Infertility: Therapeutics and Medication Profiles

Module 2 will review the mechanism of action of the typical agents used to affect infertility. Medication adverse effects, administration, storage, and other information regarding these agents will also be discussed.

Learn More ►

Fertility Module #3: Infertility: Protocols and Patient Management

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility.

Learn More ►

Fertility Module #4: Fertility Care Considerations: Infertility: Special Populations and Considerations

Module 4 will conclude with addressing some of the special considerations in patients with infertility issues. The role of the specialty pharmacy and the pharmacy care plan along with issues of adherence will also be discussed.

Learn More ►

Going Forward in Reverse: Navigating Treatment for Acute Major Bleeding

The goal of this educational activity is to enhance the pharmacist’s knowledge of the impact of acute major bleeding and patient assessment and management options.

Learn More ►

Hemophilia in Specialty Pharmacy

This activity will review hemophilia as it pertains to specialty pharmacy. Treatment choices for hemophilia A and B are discussed. Inhibitor development will be explained including diagnosis and treatment options as well as the impact to therapy.

Learn More ►

Identify Gaps and Meeting the Needs of Antimicrobial Stewardship Research

This presentation discusses gaps in the stewardship literature, simple strategies for being successful in stewardship scholarship and potential roles for you as a mentor or mentee.

Learn More ►

Implementing Change for Best Practices in Antimicrobial Stewardship

This activity will provide an overview of tools for planning and implementing new and existing antimicrobial stewardship programs. This includes elements of strategic planning, self-assessment, and determining both long term and daily priorities. The activity will also share tips for engaging team members and key stakeholders in the planning and implementation process.

Learn More ►

Infections in the Hematopoietic Cell Transplantation Setting: Improving Outcomes Through Interdisciplinary Care

This activity discusses evidence-based approaches to management of infections in the HCT setting, with a particular emphasis on interdisciplinary management.

Learn More ►

Insights and Developments in HIV Treatment Strategies

This session will discuss strategies to identify patients at risk for HIV and implement screening guideline recommendations.

Learn More ►

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP).

Learn More ►

Management and Trends in Pulmonary Arterial Hypertension

This activity will provide learners with foundational knowledge of PAH, including the role of several unique pathways.

Learn More ►

Melanoma Diagnosis and Management Considerations

This educational activity will provide an overview of the diagnosis, epidemiology, risk factors, pathology, and staging of melanoma. This activity will include an in-depth review of treatments for melanoma. Adverse events, appropriate patient monitoring, and adherence will also be discussed.

Learn More ►

Merging Microbiology and Stewardship: Making the Most of 2019 CLSI Updates on Antimicrobial Susceptibility Testing in your Stewardship Activities

This webcast will include recent CLSI antimicrobial susceptibility testing updates for gram positive and gram negative bacteria.

Learn More ►

Mobile Patient Engagement: Using Technology to Break Barriers and Reach Patients in New Ways

This activity is an engaging, detailed guide into technology use cases being employed in the market, how they are making dramatic differences in how pharmacists interact with patients, and the results from those interactions.

Learn More ►

MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series)

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately 10,000 new cases reported every year. This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

Learn More ►

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

As a chronic and progressive neurologic disease that requires lifelong, dynamic treatment via costly, high-touch medications that also require special handling and storage, multiple sclerosis therapies are often delivered via specialty pharmacy programs. This activity provides an in-depth discussion of the various therapies used in the treatment of MS.

Learn More ►

MS-103: The Role of the Specialty Pharmacy Professional in Managing MS Treatment: Care Transitions, Patient Education/Adherence, and Financial Considerations (A CSPE Core Curriculum Series)

Multiple sclerosis (MS) affects an estimated 400,000 people in the U.S., with approximately 10,000 new cases reported every year. This activity discusses the transitions of care, patient adherence strategies and financial considerations in the management of MS.

Learn More ►

MS-104: Optimizing MS Treatment: Case Studies and Applications in Specialty Pharmacy Practice (A CSPE Core Curriculum Series)

As a chronic and progressive neurologic disease that requires lifelong, dynamic treatment via costly, high-touch medications that also require special handling and storage, multiple sclerosis therapies are often delivered via specialty pharmacy programs. This capstone activity of the MS curriculum uses case studies to allow participants to apply what was learned in modules MS-101 through MS-103.

Learn More ►

New Antibiotics Now and Beyond: What’s in your Bucket?

This activity will examine antibiotics approved during this period, their spectrum of activity, data supporting use and potential place in therapy as well as important new indications for some important antibiotics.

Learn More ►

Nutrition in Cancer Care

Nutrition therapy is an important part of managing oncology patient’s adverse effects and hopefully by managing these issues it will increase the patient’s quality of life.

Learn More ►

Opioid Stewardship® - A Certificate Program for Healthcare Professionals

In collaboration with the University of Illinois College of Pharmacy, ProCE announces the scheduled release of the Opioid Stewardship® Certificate Program for Healthcare Professionals in early 2020.

Learn More ►

Opioids in the Acute Care Setting: Safety is Within Our Reach

This webinar will explore the latest trends in opioid therapy, barriers to optimal therapy and safety, and preventable errors that involve opioids. Expert speakers will discuss the latest safety considerations for these commonly-used agents, including a surprising discussion regarding the safe use of HYDROmorphone.

Learn More ►

Opioid Use Disorder: Treatment and Recovery Options

This activity will highlight the ongoing struggles that are faced within the treatment of opioid use disorder (OUD), including stigma that prevents effective engagement in treatment, as well as the continued loss of life due to opioid-related overdoses.

Learn More ►

Optimization of IVIG and SCIG: Patient Centered Care and the Role of Specialty Pharmacies

This activity will focus on primary immune deficiency along with practicalities and pitfalls when prescribing therapies for these patients. Optimizing therapy and the role of the specialty pharmacist will also be discussed.

Learn More ►

Optimizing Hepatitis C Disease Management: Implications for Specialty Pharmacy

This CE activity will present strategies to support treatment adherence, navigate cost issues, manage special populations, and ensure optimal patient outcomes.

Learn More ►

Oral Anticoagulant Reversal Agents: Deconstructing the Clinical Data

The goal of this activity is to enhance the pharmacist’s knowledge of major bleeding types and assessment. Reversal agent selection and dosing strategies will be reviewed, along with the assessment of the latest safety and efficacy data.

Learn More ►

Outsmarting Multi-Drug Resistance in Uncertain Times

Participants will gain knowledge of current antibiotic resistance trends and infections. Antimicrobial agents will be discussed, with a focus on current limitations and new therapeutic agents on the horizon.

Learn More ►

Ovarian Cancer: Implications for the Pharmacist

This session will cover the mechanism of action of the PARP inhibitors and the efficacy and safety parameters of the ovarian cancer treatment options available.

Learn More ►

Pathogens are Coming, Brace Yourself Against Gram Negative Resistance

This activity will discuss several new antimicrobial agents active against resistant Gram-negative pathogens approved in recent years.

Learn More ►

Pharmacovigilance: An Introduction to Postmarketing Drug Safety Surveillance

This activity will provide pharmacists with education on several topics surrounding post-marketing drug safety surveillance, with particular emphasis on how adverse event reports are reported, collected, and analyzed by the U.S. Food and Drug Administration, and more.

Learn More ►

Pharmacy Transplant Series: Managing Infectious Complications with a Focus on CMV

The Pharmacy Transplant Series is designed to help pharmacists better understand the very complicated post-transplant immunosuppressive regimens, the basics of immunosuppression and the issues related to infections during the post-transplant period.

Learn More ►

Pharmacy Transplant Series: The Basics of Maintenance Immunosuppression

The Pharmacy Transplant Series is designed to help pharmacists better understand the very complicated post-transplant immunosuppressive regimens, the basics of immunosuppression and the issues related to infections during the post-transplant period.

Learn More ►

Product Quality Verification of Dietary Supplements

This activity is designed to support patient counseling efforts by examining dietary supplement regulation. Topics include the Dietary Supplement Health and Education Act, voluntary quality verification programs, counseling points, and the adverse event reporting process.

Learn More ►

Prostate Cancer Treatment: Implications for the Pharmacist

This session will cover the mechanism of action of each of the prostate cancer therapeutics available and the efficacy and safety parameters.

Learn More ►

Pulmonary Arterial Hypertension: Individualized Treatment Strategies

This activity will provide pharmacists and nurses with an improved knowledge of PAH, including a review of pathophysiology, disease subcategories, diagnosis, treatment guidelines, approved therapies, disease progression, and disease monitoring recommendations.

Learn More ►

Replacing Old Practices with New Paradigms: Adopting Safe Practices for IV Push Medications

This webinar will describe the latest changes in procedural and practice expectations and will educate participants about Institute for Safe Medication Practices (ISMP) guidelines for adult IV push medications, which were developed as a result of a national summit.

Learn More ►

Research Platform Presentations

This activity will feature five projects that represent some of the exceptional research being conducted by SIDP members.

Learn More ►

Reversal Decisions in Acute Major Bleeding from Xa to Z

This activity will include an overview of the types of major bleeding and available reversal agents along with treatment options.

Learn More ►

Safety Considerations in Rabies Post-Exposure Prophylaxis

Due to the relative infrequency that clinical, emergency department, and pharmacy directors may encounter rabies, it is critical to understand the infection and necessary steps to procure and administer human rabies immunoglobulin and the rabies vaccine.

Learn More ►

Seeing Red: Managing Multidrug Resistant Gram-Negative Infections

This activity will review the current epidemiological resistance patterns of MDR gram-negative bacteria. Attendees will understand treatment strategies and patient selection criteria for the management of MDR gram-negative infections, including newly approved therapies and emerging treatment data.

Learn More ►

Sexual Harassment: Awareness and Prevention in the Healthcare Workplace (meets requirement for IL, CA*, DE, ME, NY)

This activity will assist in increasing awareness of what constitutes sexual harassment, the impact of harassment, what do to if you are harassed or a witness, the responsibilities of the employer, and the protections that are place for those reporting harassment.

Learn More ►

Should Antimicrobial Doses be Fixed? Weight Weight...Don’t Tell Me!

This webinar will provide a historical and contemporary perspective on the definition of obesity and body size description. The pharmacologic approach to initial and maintenance dose selection will be reviewed to harmonize current divergent approaches. Patient case and drug case scenarios will illustrate pragmatic methods of informing antibiotic dose selection in obesity.

Learn More ►

SIDP Antimicrobial Stewardship - A Certificate Program for Pharmacists

The Antimicrobial Stewardship Program is an innovative and intensive practice-based activity that focuses on the pharmacist's role in the appropriate use of antimicrobial agents.

Learn More ►

SIDP Antimicrobial Stewardship – A Long-Term Care Certificate Program for Pharmacists

The Society of Infectious Diseases Pharmacists (SIDP) is pleased to offer the Long-Term Care (LTC) Antimicrobial Stewardship Certificate Program. This is a practice-based certificate program focused on the role pharmacists play in the appropriate use of antimicrobial agents.

Learn More ►

SIDP Journal Club Series: Should we SWITCH to Short-Course Intravenous Antibiotics for Cellulitis?

Review an open-access journal article and complete a step-by-step discussion guide to gain insights before completing CE and/or BCIDP credit. An optional Twitter chat will be scheduled after activity launch to facilitate discussion.

Learn More ►

SIDP’s Recap of IDWeek 2019 - Part 1: Late Breaker Trials and #WhyIVaccinate; Practice-changing Publications ft. David van Duin

Ryan Shields and Erin McCreary review key posters, presentations, and other data from the IDWeek 2019 meeting. Episode 1: Late Breaker Trials and #WhyIVaccinate. Episode 2: Practice-changing publications ft. David van Duin

Learn More ►

SIDP’s Recap of IDWeek 2019 - Part 2: Provocative Titles and Pro-Con Debates; Pumpkin Spice Lessons: Phages, Posters, and Dr. Paul Sax

Ryan Shields and Erin McCreary review key posters, presentations, and other data from the IDWeek 2019 meeting. Episode 3: Provocative Titles and Pro-Con Debates. Episode 4: Pumpkin Spice Lessons: Phages, Posters, and Dr. Paul Sax.

Learn More ►

Specialty Pharmacy Considerations in the Treatment of Pulmonary Arterial Hypertension

This activity will provide pharmacists and nurses education on developments within the PAH space and perspectives on the cost/benefit equation associated with therapies in the treatment of PAH.

Learn More ►

Straight Outta Amsterdam: An ECCMID Recap

In this 4-episode podcast miniseries, Ryan Shields and Erin McCreary review key posters, presentations, and other data from the 2019 European Congress of Clinical Microbiology & Infectious Diseases

Learn More ►

Strategies To Decrease Vancomycin-associated Nephrotoxicity - What Is Their Worth?

This activity will be divided into two different strategies to decrease Vancomycin-associated nephrotoxicity. The first will examine the risk of concurrent piperacillin/tazobactam and vancomycin in terms of nephrotoxicity. The second strategy will focus on dosing Vancomycin using troughs versus AUC(area under the curve) and will examine benefits and downsides of each as well as the available Bayesian software.

Learn More ►

Strategies to Eliminate Errors in IV Compounding

This activity will provide pharmacists with an understanding of parameters to consider with IV compounding and their role in IV medication safety.

Learn More ►

Targeted Oral Chemotherapy for Lung Cancer

The management of SCLC and NSCLC is complex and staying up-to-date on the screening, diaganosis and treatment options is crucial for the specialty pharmacist caring for these patients. This activity includes a patient case study to help thoroughly explore the challenges with this disease.

Learn More ►

The Era of Targeted Therapy in Severe Asthma: Specialty Pharmacy Perspectives

This presentation will discuss the epidemiology and burden of severe asthma, the use of phenotypes and biomarkers, mechanisms of action evidence for new/emerging agents, and the pharmacist’s expanding role in asthma disease management and outcomes.

Learn More ►

The Impact of Acute Major Bleeding: Patient Outcomes, Costs, and Practical Considerations

This activity will evaluate the clinical impact of acute major bleeding and examine safety and efficacy data surrounding the use of oral anticoagulant reversal agents.

Learn More ►

The Psychology and Neuroscience of Adherence and Compliance

This activity will begin with the science of decision-making and the role of emotions. Several compliance modules will be discussed to provide specialty pharmacies practical ways to improve adherence and compliance.

Learn More ►

The Short and Long of Measurement in Antibiotic Stewardship

This CE activity is recommended for those interested in starting to measure their antibiotic stewardship program and those interested in refining their current measuring plan, specifically focusing on the inpatient setting.

Learn More ►

Treatment of Rare Seizure Disorders within Specialty Pharmacy

The initial diagnosis of epilepsy is often devastating for families. The patient and parents must be helped to understand the nature of epilepsy and its management, including etiology, prognosis, safety issues and treatment options. The goal of this presentation is to provide pharmacists with knowledge and tools to serve this patient population and their families.

Learn More ►

Treatment Strategies and Safety Updates in Multiple Sclerosis

MS treatment options have rapidly evolved and multiple safety updates for treatments were released toward the end of 2018. This activity will focus on the updated research and recommendations to provide pharmacists short and long-term management strategies for patients with MS and help to ensure improved overall care coordination.

Learn More ►

True Penicillin Allergy in the Era of Antimicrobial Resistance

This activity will provide actionable information to address incorrect or outdated beta-lactam allergy reports and to provide pharmacists, nurses, and other key stakeholders opportunities to impact care and antimicrobial stewardship best practices.

Learn More ►

Vaccination Recommendations for Shingles: Pharmacist Considerations

This activity will provide education on several topics surrounding shingles vaccination, with particular emphasis on risk factors, disease burden, ACIP recommendations, and approaches to increase the uptake of immunization.

Learn More ►

Value of Diagnostics in Antimicrobial Stewardship: An Asia-Pacific Outlook

CIDRAP-ASP hosts Prof Deborah Williamson of the University of Melbourne and Prof David Lye of Singapore's National Centre for Infectious Diseases.

Learn More ►

Value of Diagnostics to Enhance Antimicrobial Stewardship

CIDRAP-ASP hosts Dr. Ed Septimus as he presents "Value of Diagnostics to Enhance Antimicrobial Stewardship".

Learn More ►

Vancomycin Dosing: From Trough to AUC

In this activity, participants will better understand appropriate utilization of AUC-based dosing, including evidence-based support of usage and implementation strategies.

Learn More ►

Venous Thromboembolism Prevention Across Care Transitions

This activity will provide pharmacists with an improved foundational knowledge of VTE, risk stratification outlines, and oral anticoagulant options for use.

Learn More ►

What’s New for the Flu: Vaccine Prophylaxis and Treatment Updates for Pharmacists

This activity will provide pharmacists with education on the burden of influenza, expert guideline updates for treatment in high-risk populations and timing of antiviral initiation, vaccine administration for the prevention of influenza, available therapies, and approaches pharmacists can take to increase uptake of vaccine prophylaxis.

Learn More ►